Focus

New Covid lab development ready for next step

Fanshawe’s Centre for Research and Innovation announces a new laboratory development that can speed up validation of effectiveness for potential Covid-19 treatments

FANSHAWE COLLEGE’S CENTRE for Research and Innovation has developed a safe, rapid and inexpensive method to identify the effectiveness of potential Covid-19 drug treatments.

Principal investigator Abdulla Mahboob, PhD in biotechnology with experience in the biochemistry of RNA viruses, has developed artificial copies of the SARS-COV-2 virus called ‘replicons’ that can be transferred into mammalian cells.

“We are ready to work with a commercial partner who can actively participate in this venture to take our proof-of-concept success from our small college lab to large-scale application” ―Abdulla Mahboob

The replicons are non-infectious, containing all the non-structural genes of the virus, but missing the genes allowing the virus to assemble into an infectious agent. This enables testing of new COVID-19 drug therapies against the replicon outside of the more expensive biosafety level-2 laboratories.

Fanshawe’s replicon has also been developed with two problematic mutations in the current pandemic: one that is associated with higher mortality and another that is resistant against the current treatment Remdesivir. Any pharmaceutical company would be able to use the lab-created replicons to rapidly screen a library of potential drug treatments for effectiveness against Covid-19.

Story Continues Below

“We are ready to work with a commercial partner who can actively participate in this venture to take our proof-of-concept success from our small college lab to large-scale application,” says Mahboob. “Our development, called the ‘Flexicon’, can make treatment testing much faster and more accessible to many labs around the world.”

Mahboob’s team is simultaneously working with the National Institutes of Health in the United States to validate a peptide-inhibitor treatment option for Covid-19.

“The faster we can effectively test the latest treatment options, the better our chances of potentially saving lives,” adds Mahboob.

Recent Posts

London Inc. Weekly

London Inc. Weekly: A summary of regional business news from the past week

4 days ago

Dispatch

Dispatch: A summary of recent business appointments and announcements, plus upcoming events for the week ahead

4 days ago

Price check

Price check: High- and low-priced real estate listings around town this week

6 days ago

Commercial Activity: May 28, 2025

A summary of recent commercial real estate activity in London

6 days ago

Home of the Week: 173 Langarth Street East

173 Langarth Street East: $1,399,999 for a custom-designed modern home in Wortley Village

6 days ago

Food Basics celebrates 30th anniversary by expanding in London, Ontario

Food Basics marks their 30th anniversary with the opening of its latest store ― its 147th location in Ontario ―…

7 days ago